Last reviewed · How we verify
Unstable angina
Approved treatments
- Lovenox (Preservative Free) · Sanofi
Lovenox works by enhancing the activity of antithrombin-III to inhibit blood clotting. - Integrilin · Merck & Co.
Integrilin blocks the binding of fibrinogen to platelets, preventing them from clumping together and forming clots. - Plavix · Generic (originally Sanofi/BMS)
Irreversibly blocks the P2Y12 ADP receptor on platelets, inhibiting platelet aggregation and preventing arterial thrombosis. - Lovenox · University of Monastir
- Enoxaparin · Dana-Farber Cancer Institute
- integrilin · University of Cincinnati
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Unstable angina patent landscape — cliff calendar, originator estates, attackable patents
- Unstable angina treatment landscape brief
- Unstable angina treatment updates RSS
Frequently asked questions about Unstable angina
What drugs treat Unstable angina?
Tracked treatments include Lovenox (Preservative Free), Integrilin, Plavix, Lovenox, Enoxaparin, integrilin.
What is the treatment for Unstable angina?
Standard treatment for Unstable angina includes Lovenox (Preservative Free), Integrilin, Plavix, Lovenox, Enoxaparin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Unstable angina patent cliff · Unstable angina CI report
- Treatment: Lovenox (Preservative Free) · Sanofi
- Treatment: Integrilin · Merck & Co.
- Treatment: Plavix · Generic (originally Sanofi/BMS)
- Treatment: Lovenox · University of Monastir
- Treatment: Enoxaparin · Dana-Farber Cancer Institute
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing